查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528925

行动心臟遥测系统市场 - 按产品类型、适应症、最终用途 - 全球预测

Mobile Cardiac Telemetry Systems Market - By Product Type, Indication, End-use - Global Forecast
出版日期: | 出版商: Global Market Insights Inc. | 英文 105 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在不断推出的产品和该领域的进步的推动下，全球行动心臟遥测系统市场在 2024 年至 2032 年间的复合年增长率将达到 12.1%。这些系统可以在传统临床环境之外即时监测心臟活动，从而对心臟疾病提供早期检测和介入。领先的公司正在创新，推出更小、更便携的设备，配备先进的传感器和连接功能，提高患者的舒适度和资料准确性。例如，2024 年 5 月，Vivalink 推出了专为行动心臟遥测 (MCT) 和动态心电图监测量身定制的综合技术解决方案。此整合解决方案将远端患者监护 (RPM) 技术与检测心律不整的先进演算法相结合。

全球心血管疾病的增加，加上人口老化，进一步推动了市场的发展。移动心臟遥测系统可以长时间持续监测，提高诊断准确性及患者治疗效果。此外，将人工智慧和机器学习整合到这些系统中可以增强资料解释和诊断能力。随着医疗保健提供者优先考虑远端患者监测和个人化护理，行动心臟遥测系统市场有望透过持续的技术创新实现显着成长。

行动心臟遥测系统产业的整体规模根据产品类型、适应症、最终用途和地区进行分类。

由于贴片解决方案在连续心臟监测方面的便利性和有效性，行动心臟遥测系统市场对基于贴片的解决方案的需求不断增长。这些穿戴式贴片提供心臟活动的即时资料，使患者和医疗保健提供者能够深入了解心臟健康状况，而不受传统监测设备的限制。基于贴片的系统因其舒适性、易用性以及及时检测心律不整和其他心臟异常的能力而越来越受欢迎。随着医疗保健行业转向远端患者监测和个人化护理，在持续的技术进步和改善的患者治疗结果的支持下，对基于贴片的行动心臟遥测系统的需求预计将会增长。

由于冠状动脉疾病 (CAD) 盛行率不断上升，移动心臟遥测系统市场对冠状动脉监测解决方案的需求不断增加。这些系统能够持续监测患者的心臟活动，这对于早期发现和管理 CAD 相关问题至关重要。行动心臟遥测提供心臟功能的即时资料，帮助医疗保健提供者及时介入以预防併发症。由于 CAD 是全球死亡的主要原因，因此对能够远端检测和监测冠状动脉状况的有效监测解决方案的需求正在推动市场成长并改善患者护理和治疗结果。

由于医疗保健技术的进步和心血管疾病盛行率的增加，欧洲的行动心臟遥测系统市场正经历着强劲的需求。这些系统可在临床环境之外持续监测心臟活动，并支持早期诊断和个人化治疗。欧洲医疗保健系统优先考虑远距患者监测，以改善治疗结果并减少住院率。随着人口老化和慢性病发病率上升，对高效心臟监测解决方案的需求日益增长。行动心臟遥测技术的创新，包括增强的资料分析和连接性，满足了这些需求，为欧洲市场在未来几年的显着成长奠定了基础。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心臟疾病的发生率增加
      • 政府优惠政策
      • 人口老化加剧
    • 产业陷阱与挑战
      • 缺乏专业培训和教育
      • 严格的监管政策和品质控制标准
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032

  • 主要趋势
  • 铅基
  • 基于补丁

第 6 章：市场估计与预测：按指标划分，2021 - 2032 年

  • 主要趋势
  • 心绞痛
  • 冠状动脉疾病
  • 动脉粥状硬化
  • 心臟衰竭
  • 中风
  • 其他适应症

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 专科诊所
  • 诊断中心
  • 家庭护理设置
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • ACS Diagnostics
  • Baxter International Inc.
  • BIOTRICITY INC.
  • Boston Scientific Cardiac Diagnostics Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medicomp Systems
  • ScottCare Cardiovascular Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
简介目录
Product Code: 9376

Global Mobile Cardiac Telemetry Systems Market will witness a 12.1% CAGR between 2024 and 2032, fueled by continuous product launches and advancements in the field. These systems offer real-time monitoring of cardiac activities outside of traditional clinical settings, providing early detection and intervention for cardiac conditions. Leading companies are innovating with smaller, more portable devices equipped with advanced sensors and connectivity features, enhancing patient comfort and data accuracy. For instance, in May 2024, Vivalink introduced a comprehensive technology solution tailored for Mobile Cardiac Telemetry (MCT) and Holter monitoring. This integrated solution combines remote patient monitoring (RPM) technologies with advanced algorithms for detecting arrhythmias.

The rise in cardiovascular diseases globally, coupled with an aging population, drives the market further. Mobile cardiac telemetry systems enable continuous monitoring over extended periods, improving diagnostic accuracy and patient outcomes. Additionally, the integration of artificial intelligence and machine learning into these systems enhances data interpretation and diagnostic capabilities. As healthcare providers prioritize remote patient monitoring and personalized care, the Mobile Cardiac Telemetry Systems Market is poised for significant growth with ongoing technological innovations.

The overall Mobile Cardiac Telemetry Systems Industry size is classified based on the product type, indication, end-use, and region.

The Mobile Cardiac Telemetry Systems Market is experiencing rising demand for patch-based solutions due to their convenience and effectiveness in continuous heart monitoring. These wearable patches provide real-time data on cardiac activity, offering patients and healthcare providers insights into heart health without the constraints of traditional monitoring devices. Patch-based systems are gaining popularity for their comfort, ease of use, and ability to detect arrhythmias and other cardiac abnormalities promptly. As the healthcare industry shifts towards remote patient monitoring and personalized care, the demand for patch-based mobile cardiac telemetry systems is expected to grow, supported by ongoing technological advancements and improved patient outcomes.

The Mobile Cardiac Telemetry Systems Market is seeing increased demand for coronary artery monitoring solutions, driven by the rising prevalence of coronary artery disease (CAD). These systems enable continuous monitoring of patients' heart activity, crucial for the early detection and management of CAD-related issues. Mobile cardiac telemetry provides real-time data on heart function, helping healthcare providers intervene promptly to prevent complications. With CAD being a leading cause of mortality worldwide, the need for effective monitoring solutions that can detect and monitor coronary artery conditions remotely is driving market growth and enhancing patient care and outcomes.

The Mobile Cardiac Telemetry Systems Market in Europe is experiencing robust demand driven by advancements in healthcare technology and increasing cardiovascular disease prevalence. These systems offer continuous monitoring of cardiac activity outside clinical settings, supporting early diagnosis and personalized treatment. European healthcare systems prioritize remote patient monitoring to improve outcomes and reduce hospitalizations. As aging populations and chronic disease rates rise, there's a growing need for efficient cardiac monitoring solutions. Innovations in mobile cardiac telemetry, including enhanced data analytics and connectivity, cater to these needs, positioning the European market for significant growth in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of cardiac disorders
      • 3.2.1.2 Favorable government policies
      • 3.2.1.3 Growing aging population
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of professional training & education
      • 3.2.2.2 Stringent regulatory policies and quality control standards
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Lead-based
  • 5.3 Patch-based

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Angina pectoris
  • 6.3 Coronary artery disease
  • 6.4 Atherosclerosis
  • 6.5 Heart failure
  • 6.6 Stroke
  • 6.7 Other indications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Specialty clinics
  • 7.4 Diagnostic centers
  • 7.5 Homecare settings
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 ACS Diagnostics
  • 9.2 Baxter International Inc.
  • 9.3 BIOTRICITY INC.
  • 9.4 Boston Scientific Cardiac Diagnostics Inc.
  • 9.5 iRhythm Technologies, Inc.
  • 9.6 Koninklijke Philips N.V.
  • 9.7 Medicomp Systems
  • 9.8 ScottCare Cardiovascular Solutions
  • 9.9 Telerhythmics LLC
  • 9.10 Zoll Medical Corporation